
Background: The Global Registry of Acute Coronary Events (GRACE) score is widely used for risk stratification in patients with non–ST-elevation myocardial infarction (NSTEMI). However, it does not account for metabolic factors such as insulin resistance, which may contribute to residual cardiovascular risk. The triglyceride–glucose (TyG) index has emerged as a simple surrogate marker of insulin resistance with potential prognostic value. This study aimed to evaluate the incremental value of the TyG index beyond the GRACE score for predicting short-term outcomes.Methods: In this retrospective observational design study, 110 patients with NSTEMI undergoing percutaneous coronary intervention (PCI) at Adam Malik Hospital, Medan, Indonesia, between January and December 2024 were included. The GRACE score and TyG index were calculated at admission. The primary endpoint was 30-day major adverse cardiovascular events (MACE). Discriminatory performance was assessed using receiver operating characteristic (ROC) curve analysis.Results: During 30-day follow-up, MACE occurred in 29 patients (26.4%). The GRACE score demonstrated good predictive performance (AUC 0.801; 95% CI 0.702–0.901). The TyG index alone showed moderate discrimination (AUC 0.717). The addition of the TyG index to the GRACE score significantly improved predictive accuracy (AUC 0.853; 95% CI 0.814–0.903; p < 0.05).Conclusions: The incorporation of the TyG index into the GRACE score provides incremental prognostic value for predicting 30-day MACE in NSTEMI patients undergoing PCI. This combined approach may enhance risk stratification by integrating metabolic and clinical risk factors.
Background: Reduced functional capacity and limited participation in cardiac rehabilitation (CR) adversely affect recovery among patients with coronary artery disease (CAD). This study evaluated functional capacity, CR participation, perceived barriers, and factors associated with reduced functional capacity and CR non-participation among patients with CAD.Methods: A hospital-based cross-sectional study was conducted among 178 clinically stable adults with CAD attending the University of Lahore Teaching Hospital and the University Institute of Physical Therapy clinics, Pakistan, from March to June 2026. Functional capacity was assessed using the Duke Activity Status Index (DASI), and perceived barriers were evaluated using the Cardiac Rehabilitation Barriers Scale (CRBS). Multivariable linear and logistic regression analyses were performed to identify predictors of reduced functional capacity and CR non-participation.Results: The mean DASI score was 20.4 ± 11.3, corresponding to a mean estimated VO2 peak of 18.4 ± 4.9 mL/kg/min, and 34.3% of participants had poor functional capacity. Overall, 41% received CR referral, 23% enrolled in CR programs, 12.4% completed the prescribed program, and 81.5% met the criteria for CR non-participation. The mean CRBS score was 3.24 ± 0.68, with socioeconomic/logistical barriers showing the highest domain score (3.68 ± 0.74). Older age, higher body mass index, lower left ventricular ejection fraction, and previous coronary artery bypass graft surgery independently predicted reduced functional capacity, whereas the absence of CR referral was the strongest predictor of CR non-participation (aOR = 8.42, 95% CI: 3.14–22.58). Functional capacity was inversely correlated with perceived barriers (ρ =-0.442, p < 0.001).Conclusion: Patients with CAD demonstrated reduced functional capacity, low CR referral, enrollment, participation, and completion rates, together with substantial perceived barriers to rehabilitation. Strategies to strengthen referral pathways, improve patient education, and expand access to CR services may improve rehabilitation participation and functional recovery.
Quadricuspid aortic valve is a rare congenital anomaly usually associated with regurgitation. A young woman underwent surveillance after cardiovascular magnetic resonance imaging demonstrated four equal cusps in diastole but bicuspid-type systolic opening from fusion of the left and non-coronary cusps. By 2025, eccentric regurgitation was severe on echocardiography and moderate-to-severe on magnetic resonance imaging, with a regurgitant fraction of 31% and mild left ventricular dilatation. Increasing breathlessness and declining peak oxygen uptake prompted multidisciplinary review. Valve replacement with ascending aortic support was recommended, and she was considered suitable for a Ross procedure with personalised external aortic root support.
Anomalous aortic origin of a coronary artery may remain undetected during standard pre-participation cardiovascular screening. We report a 45-year-old asymptomatic marathon runner with normal physical examination and electrocardiogram. Transthoracic echocardiography showed a retroaortic tubular vascular structure with color flow, prompting coronary computed tomography angiography. Imaging demonstrated anomalous origin of the left anterior descending artery from the right sinus of Valsalva with an interarterial course and a coexisting retroaortic left circumflex artery. Functional and rhythm testing were reassuring. This case illustrates the potential incremental diagnostic value of echocardiography in selected athlete evaluations.
Background: Microvascular complications—diabetic retinopathy, nephropathy, and neuropathy—remain major contributors to morbidity in type 2 diabetes mellitus. Statins, widely used for cardiovascular risk reduction, have been proposed to exert additional microvascular protective effects via pleiotropic mechanisms, though evidence remains inconsistent.Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines, including randomized controlled trials and observational studies evaluating statin efficacy in preventing microvascular complications. Data on demographics, biochemical parameters, and clinical outcomes were extracted. A random-effects model (RevMan 5.4.1) was used, with outcomes reported as odds ratios (OR) and mean differences (MD) with 95% confidence intervals (CI).Results: Seven clinical trials were included. Statin use showed a statistically significant association with diabetic retinopathy progression (OR: 1.86; 95% CI: 1.72–2.00; P < 0.00001); however, this finding should be interpreted with caution due to substantial heterogeneity (I2 = 97%). Nephropathy events were significantly reduced (OR: 0.75; 95% CI: 0.70–0.80; P < 0.00001; I2 = 0%). Retinopathy incidence also declined (OR: 0.43; 95% CI: 0.33–0.55; P < 0.00001; I2 = 0%). A modest improvement in eGFR was observed (MD: 0.23; 95% CI: 0.22–0.24; P < 0.00001). Qualitative findings suggested reductions in VEGF, bFGF, lipids, and inflammatory markers, though clinical relevance remained uncertain.Conclusion: Statins may confer protective effects against microvascular complications in type 2 diabetes, particularly retinopathy and nephropathy events. However, heterogeneity and population-specific differences warrant cautious interpretation.